RCKT
Price
$3.42
Change
+$0.13 (+3.95%)
Updated
Nov 28 closing price
Capitalization
357.13M
93 days until earnings call
Intraday BUY SELL Signals
TVTX
Price
$35.41
Change
-$0.85 (-2.34%)
Updated
Nov 28 closing price
Capitalization
3.17B
82 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

RCKT vs TVTX

Header iconRCKT vs TVTX Comparison
Open Charts RCKT vs TVTXBanner chart's image
Rocket Pharmaceuticals
Price$3.42
Change+$0.13 (+3.95%)
Volume$1.11M
Capitalization357.13M
Travere Therapeutics
Price$35.41
Change-$0.85 (-2.34%)
Volume$761.35K
Capitalization3.17B
RCKT vs TVTX Comparison Chart in %
RCKT
Daily Signal:
Gain/Loss:
TVTX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
RCKT vs. TVTX commentary
Nov 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RCKT is a StrongBuy and TVTX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 30, 2025
Stock price -- (RCKT: $3.42 vs. TVTX: $35.41)
Brand notoriety: RCKT and TVTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RCKT: 44% vs. TVTX: 41%
Market capitalization -- RCKT: $357.13M vs. TVTX: $3.17B
RCKT [@Biotechnology] is valued at $357.13M. TVTX’s [@Biotechnology] market capitalization is $3.17B. The market cap for tickers in the [@Biotechnology] industry ranges from $110.02B to $0. The average market capitalization across the [@Biotechnology] industry is $2.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RCKT’s FA Score shows that 1 FA rating(s) are green whileTVTX’s FA Score has 1 green FA rating(s).

  • RCKT’s FA Score: 1 green, 4 red.
  • TVTX’s FA Score: 1 green, 4 red.
According to our system of comparison, TVTX is a better buy in the long-term than RCKT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RCKT’s TA Score shows that 6 TA indicator(s) are bullish while TVTX’s TA Score has 3 bullish TA indicator(s).

  • RCKT’s TA Score: 6 bullish, 4 bearish.
  • TVTX’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, RCKT is a better buy in the short-term than TVTX.

Price Growth

RCKT (@Biotechnology) experienced а +16.72% price change this week, while TVTX (@Biotechnology) price change was +2.08% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.92%. For the same industry, the average monthly price growth was +1.16%, and the average quarterly price growth was +72.91%.

Reported Earning Dates

RCKT is expected to report earnings on Mar 02, 2026.

TVTX is expected to report earnings on Feb 19, 2026.

Industries' Descriptions

@Biotechnology (+6.92% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TVTX($3.17B) has a higher market cap than RCKT($357M). TVTX YTD gains are higher at: 103.272 vs. RCKT (-72.792). TVTX has higher annual earnings (EBITDA): -22.58M vs. RCKT (-245.09M). RCKT has more cash in the bank: 271M vs. TVTX (255M). RCKT has less debt than TVTX: RCKT (25.2M) vs TVTX (330M). TVTX has higher revenues than RCKT: TVTX (436M) vs RCKT (0).
RCKTTVTXRCKT / TVTX
Capitalization357M3.17B11%
EBITDA-245.09M-22.58M1,085%
Gain YTD-72.792103.272-70%
P/E RatioN/AN/A-
Revenue0436M-
Total Cash271M255M106%
Total Debt25.2M330M8%
FUNDAMENTALS RATINGS
RCKT vs TVTX: Fundamental Ratings
RCKT
TVTX
OUTLOOK RATING
1..100
313
VALUATION
overvalued / fair valued / undervalued
1..100
12
Undervalued
84
Overvalued
PROFIT vs RISK RATING
1..100
10062
SMR RATING
1..100
96100
PRICE GROWTH RATING
1..100
6435
P/E GROWTH RATING
1..100
10033
SEASONALITY SCORE
1..100
8590

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RCKT's Valuation (12) in the Biotechnology industry is significantly better than the same rating for TVTX (84). This means that RCKT’s stock grew significantly faster than TVTX’s over the last 12 months.

TVTX's Profit vs Risk Rating (62) in the Biotechnology industry is somewhat better than the same rating for RCKT (100). This means that TVTX’s stock grew somewhat faster than RCKT’s over the last 12 months.

RCKT's SMR Rating (96) in the Biotechnology industry is in the same range as TVTX (100). This means that RCKT’s stock grew similarly to TVTX’s over the last 12 months.

TVTX's Price Growth Rating (35) in the Biotechnology industry is in the same range as RCKT (64). This means that TVTX’s stock grew similarly to RCKT’s over the last 12 months.

TVTX's P/E Growth Rating (33) in the Biotechnology industry is significantly better than the same rating for RCKT (100). This means that TVTX’s stock grew significantly faster than RCKT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
RCKTTVTX
RSI
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
74%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
77%
Momentum
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
70%
MACD
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
79%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
77%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
78%
Advances
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 4 days ago
78%
Declines
ODDS (%)
Bearish Trend 10 days ago
86%
Bearish Trend 9 days ago
78%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
85%
Aroon
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
RCKT
Daily Signal:
Gain/Loss:
TVTX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TRLUX25.220.14
+0.56%
T. Rowe Price Lrg Cp Va Inv
PFPGX31.120.16
+0.52%
Parnassus Growth Equity Institutional
MNVRX30.130.09
+0.30%
Madison Large Cap R6
GSIFX31.92N/A
N/A
Goldman Sachs International Eq ESG A
ALLIX123.78N/A
N/A
AB Large Cap Growth I